VARIVAX (Merck Sharp & Dohme Corp.)


Welcome to the PulseAid listing for the VARIVAX drug offered from Merck Sharp & Dohme Corp.. This Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.

LABELER NAME / MANUFACTURER: Merck Sharp & Dohme Corp.
NON-PROPRIETARY NAME: Varicella Virus Vaccine Live
SUBSTANCE NAME: VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN
TYPE: VACCINE
PHARMA CLASS: Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1995-03-17
END MARKETING DATE: 0000-00-00


VARIVAX VACCINE Details:

Item DescriptionVARIVAX from Merck Sharp & Dohme Corp.
LABELER NAME: Merck Sharp & Dohme Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 1350([PFU]/.5mL)
START MARKETING DATE: 1995-03-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0006-4826_57f23194-526d-47d5-b2d0-d5cf06c7b544
PRODUCT NDC: 0006-4826
APPLICATION NUMBER: BLA103552

Other VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Merck Sharp & Dohme Corp.VARIVAX